Contreras-García, I. J., Gómez-Lira, G., Phillips-Farfán, B. V., Pichardo-Macías, L. A., García-Cruz, M. E., Chávez-Pacheco, J. L., & Mendoza-Torreblanca, J. G. (2021). Synaptic Vesicle Protein 2A Expression in Glutamatergic Terminals Is Associated with the Response to Levetiracetam Treatment. Brain Sci.

Contreras-García, Itzel Jatziri, Gisela Gómez-Lira, Bryan Víctor Phillips-Farfán, Luz Adriana Pichardo-Macías, Mercedes Edna García-Cruz, Juan Luis Chávez-Pacheco, and Julieta G. Mendoza-Torreblanca. "Synaptic Vesicle Protein 2A Expression in Glutamatergic Terminals Is Associated With the Response to Levetiracetam Treatment." Brain Sci 2021.

Contreras-García, Itzel Jatziri, et al. "Synaptic Vesicle Protein 2A Expression in Glutamatergic Terminals Is Associated With the Response to Levetiracetam Treatment." Brain Sci 2021.